Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 20/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL544413 | 0.99 | CTSA (0.45) | CTSA | |
| SCHEMBL912798 | 0.94 | CTSA (0.45) | CTSA | |
| SCHEMBL912797 | 0.93 | CTSA (0.42) | CTSA | |
| SCHEMBL2492101 | 0.93 | CTSA (0.43) | CTSA | |
| Hydrochloric Acid SCHEMBL912913 | 0.92 | CTSA (0.42) | CTSA | |
| SCHEMBL2490827 | 0.90 | CTSA (0.44) | CTSA | |
| Hydrochloric Acid SCHEMBL545085 | 0.89 | CTSA (0.43) | CTSA | |
| Hydrochloric Acid SCHEMBL544784 | 0.89 | CTSA (0.43) | CTSA | |
| SCHEMBL912801 | 0.88 | CTSA (0.40) | CTSA | |
| SCHEMBL914205 | 0.87 | CTSA (0.42) | CTSA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8466292-B2 | 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin II receptor antagonists | SANOFI (FR) | 2013-06-18 | — | — | US | claimed |
| EP-2238110-B1 | 5.6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF AS ANTAGONISTS FOR UROTENSINE II RECEPTORS | SANOFI SA (FR) | 2011-10-26 | — | — | EP | claimed |
| EP-2238110-B1 | 5.6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF AS ANTAGONISTS FOR UROTENSINE II RECEPTORS | SANOFI SA (FR) | 2011-10-26 | — | — | EP | disclosed |